MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
CHEBI:74963 chebi:74963 IESVDEZGAHUQJU-ZLBXKVHBSA-N | 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine (2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]-3-(palmitoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate 1-C16:0-2-C22:6(omega-3)-phosphatidylcholine 1-Palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine 1-Palmitoyl-2-docosahexaenoylphosphatidylcholine 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphocholine 1-palmitoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphocholine 1-palmitoyl-2-docosahexaenoyl-GPC 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) GPC(16:0/22:6) PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) PC(16:0/22:6) PC(16:0/22:6omega3) PC(38:6) Phosphatidylcholine(16:0/22:6) Phosphatidylcholine(16:0/22:6omega3) Phosphatidylcholine(38:6) |
vmhM:g3pc_1hdca2crvnc vmhM:g3pc_1hdca2crvnc vmhmetabolite:g3pc_1hdca2crvnc vmhmetabolite:g3pc_1hdca2crvnc IESVDEZGAHUQJU-ZLBXKVHBSA-N | 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine (CD3-16.0)(22.6)PC 1-(16,16,16-Trideuteriopalmitoyl)-2-docosahexaenoyl-sn-glycero-3-phosphocholine 1-C16:0-2-C22:6(Omega-3)-phosphatidylcholine 1-Hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphocholine 1-Hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine 1-Palmitoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphocholine 1-Palmitoyl-2-docosahexaenoyl-GPC 1-Palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) 1-Palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine 1-Palmitoyl-2-docosahexaenoylphosphatidylcholine Cellular membrane Dietary supplement Digestion Extracellular region Fauna GPC(16:0/22:6) GPCho(16:0/22:6) GPCho(38:6) Inner membrane Lecithin Lipid metabolic process Membrane integrity agent Membrane stability agent Nutraceutical PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) PC(16:0/22:6) PC(16:0/22:6omega3) PC(38:6) PDCH-GPC PDPC Phosphatidylcholine(16:0/22:6) Phosphatidylcholine(16:0/22:6omega3) Phosphatidylcholine(38:6) Signal transduction Surface-active agent |
SLM:000000805 slm:000000805 IESVDEZGAHUQJU-ZLBXKVHBSA-N | 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Phosphatidylcholine (16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
lipidmaps:LMGP01012137 lipidmapsM:LMGP01012137 IESVDEZGAHUQJU-ZLBXKVHBSA-N | PC 16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z) 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine PC 38:6 PC(16:0_22:6) PC(38:6) |
| hmdb:HMDB0007991 IESVDEZGAHUQJU-ZLBXKVHBSA-N | PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (2-{[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]-3-(hexadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium (CD3-16.0)(22.6)PC 1-(16,16,16-Trideuteriopalmitoyl)-2-docosahexaenoyl-sn-glycero-3-phosphocholine 1-C16:0-2-C22:6(Omega-3)-phosphatidylcholine 1-Hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphocholine 1-Hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine 1-Palmitoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphocholine 1-Palmitoyl-2-docosahexaenoyl-GPC 1-Palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) 1-Palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine 1-Palmitoyl-2-docosahexaenoylphosphatidylcholine GPC(16:0/22:6) GPCho(16:0/22:6) GPCho(38:6) Lecithin PC(16:0/22:6) PC(16:0/22:6omega3) PC(38:6) PDCH-GPC PDPC Phosphatidylcholine(16:0/22:6) Phosphatidylcholine(16:0/22:6omega3) Phosphatidylcholine(38:6) |
metacyc.compound:CPD-26127 metacycM:CPD-26127 IESVDEZGAHUQJU-ZLBXKVHBSA-N | PC(16:0/22:6) 1-16:0-2-22:6-phosphatidylcholine 16:0-22:6-PC phosphatidylcholine (1-16:0-2-22:6) |
hmdb:HMDB07991 chebi:73800 vmhM:g3pc_1hdca_2crvnc vmhM:g3pc_1hdca_2crvnc vmhM:M_g3pc_1hdca2crvnc | secondary/obsolete/fantasy identifier |